Literature DB >> 9031815

Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers.

L O Bauer1.   

Abstract

P300 event related brain potentials were studied in 49 cocaine dependent patients, abstinent for 1-5 months, and 20 healthy, non-drug-dependent controls. Patients were assigned to one of two subgroups based on the presence/absence of a DSM-IIIR diagnosis of antisocial personality disorder (ASPD). Analyses of P300s recorded during a visual selective attention task revealed reduced amplitudes at frontal electrode sites among patients with ASPD, relative to the ASPD negative patient and control groups. The frontal P300 decrement was significantly correlated with the number of childhood conduct disorder symptoms, but not with the presence/absence of a family history of alcoholism. A secondary analysis examined the relationship between P300 amplitude among cocaine dependent patients and their future behavior, i.e., relapse versus continued abstinence. Discriminant function analysis revealed that P300 amplitude alone accurately identified 70.6% of the patients who later relapsed, and 53.3% of the patients who did not.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9031815     DOI: 10.1016/s0376-8716(96)01311-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Violent offending predicts P300 amplitude.

Authors:  Edward M Bernat; Jason R Hall; Benjamin V Steffen; Christopher J Patrick
Journal:  Int J Psychophysiol       Date:  2007-05-03       Impact factor: 2.997

3.  Transdermal nicotine administration and the electroencephalographic activity of substance abusers in treatment.

Authors:  Natalie A Ceballos; Rick Tivis; Robert Prather; Sara Jo Nixon
Journal:  J Addict Med       Date:  2008       Impact factor: 3.702

4.  Compromised sensitivity to monetary reward in current cocaine users: an ERP study.

Authors:  Rita Z Goldstein; Muhammad A Parvaz; Thomas Maloney; Nelly Alia-Klein; Patricia A Woicik; Frank Telang; Gene-Jack Wang; Nora D Volkow
Journal:  Psychophysiology       Date:  2008-05-30       Impact factor: 4.016

Review 5.  Genetic psychophysiology: advances, problems, and future directions.

Authors:  Andrey P Anokhin
Journal:  Int J Psychophysiol       Date:  2014-04-13       Impact factor: 2.997

6.  Electrophysiological responses to affective stimuli in Mexican Americans: Relationship to alcohol dependence and personality traits.

Authors:  José R Criado; Cindy L Ehlers
Journal:  Pharmacol Biochem Behav       Date:  2007-08-10       Impact factor: 3.533

Review 7.  Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.

Authors:  Rebecca J Houston; Nicolas J Schlienz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23

8.  A pilot study revealing impaired P50 gating in antisocial personality disorder.

Authors:  Marijn Lijffijt; F Gerard Moeller; Nash N Boutros; S Burroughs; Joel L Steinberg; Scott D Lane; Alan C Swann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  Event-Related Potential Study of Executive Dysfunctions in a Speeded Reaction Task in Cocaine Addiction.

Authors:  Estate Sokhadze; Christopher Stewart; Michael Hollifield; Allan Tasman
Journal:  J Neurother       Date:  2008-12-01

10.  Brain potentials measured during a Go/NoGo task predict completion of substance abuse treatment.

Authors:  Vaughn R Steele; Brandi C Fink; J Michael Maurer; Mohammad R Arbabshirani; Charles H Wilber; Adam J Jaffe; Anna Sidz; Godfrey D Pearlson; Vince D Calhoun; Vincent P Clark; Kent A Kiehl
Journal:  Biol Psychiatry       Date:  2013-10-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.